Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...

Reports first quarter revenue of $0.4 billion, with approximately 80% of revenue from international marketsReports ...

NewcelX and Eledon Pharmaceuticals are collaborating to advance one of the few scalable approaches to a potential functional cure in Type 1 ...

New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized methodologies for deriving induced ...

National Disaster Management Authority, working with the Department of Telecommunications, is running nationwide trials of a ...

Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2026 Agios Financial Results and Business ...

The sBLA submission is based on the first interim analysis (IA1) of HERIZON-GEA-01, a global Phase 3 clinical trial designed to evaluate ZIIHERA plus chemotherapy, with and without TEVIMBRA, compared ...

Approval received in advance of FDA-assigned PDUFA date of June 5, 2026; Arvinas and Pfizer remain on track to announce ...

Good afternoon, and thank you for joining us. With me on today's call is our CEO, Tim Turner; our CFO, Janice Hamilton; our CEO of Underwriting Managers, Miles Wuller; and our Head of Investor ...

Explore how bioprocess analytics enables real-time monitoring, process optimization, and improved consistency in ...